115 related articles for article (PubMed ID: 9652750)
1. Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts.
Bafico A; Gazit A; Wu-Morgan SS; Yaniv A; Aaronson SA
Oncogene; 1998 May; 16(21):2819-25. PubMed ID: 9652750
[TBL] [Abstract][Full Text] [Related]
2. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the growth characteristics of the fibroblast cell line C3H 10T1/2 by members of the Wnt gene family.
Bradbury JM; Niemeyer CC; Dale TC; Edwards PA
Oncogene; 1994 Sep; 9(9):2597-603. PubMed ID: 8058323
[TBL] [Abstract][Full Text] [Related]
4. Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function.
Humphreys RC; Rosen JM
Cell Growth Differ; 1997 Aug; 8(8):839-49. PubMed ID: 9269893
[TBL] [Abstract][Full Text] [Related]
5. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
6. The biochemical properties and transforming potential of human Wnt-2 are similar to Wnt-1.
Blasband A; Schryver B; Papkoff J
Oncogene; 1992 Jan; 7(1):153-61. PubMed ID: 1371336
[TBL] [Abstract][Full Text] [Related]
7. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
Li YX; Papkoff J; Sarkar NH
Virology; 1999 Mar; 255(1):138-49. PubMed ID: 10049829
[TBL] [Abstract][Full Text] [Related]
8. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
9. Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation.
Liu BY; Kim YC; Leatherberry V; Cowin P; Alexander CM
Oncogene; 2003 Dec; 22(58):9243-53. PubMed ID: 14681683
[TBL] [Abstract][Full Text] [Related]
10. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
[TBL] [Abstract][Full Text] [Related]
11. Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion.
Uyttendaele H; Soriano JV; Montesano R; Kitajewski J
Dev Biol; 1998 Apr; 196(2):204-17. PubMed ID: 9576833
[TBL] [Abstract][Full Text] [Related]
12. Murine Nr4a1 and Herpud1 are up-regulated by Wnt-1, but the homologous human genes are independent from beta-catenin activation.
Chtarbova S; Nimmrich I; Erdmann S; Herter P; Renner M; Kitajewski J; Müller O
Biochem J; 2002 Nov; 367(Pt 3):723-8. PubMed ID: 12153396
[TBL] [Abstract][Full Text] [Related]
13. Wingless, the Drosophila homolog of the proto-oncogene Wnt-1, can transform mouse mammary epithelial cells.
Ramakrishna NR; Brown AM
Dev Suppl; 1993; ():95-103. PubMed ID: 8049493
[TBL] [Abstract][Full Text] [Related]
14. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
15. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
[TBL] [Abstract][Full Text] [Related]
17. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
Labbé E; Lock L; Letamendia A; Gorska AE; Gryfe R; Gallinger S; Moses HL; Attisano L
Cancer Res; 2007 Jan; 67(1):75-84. PubMed ID: 17210685
[TBL] [Abstract][Full Text] [Related]
19. A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis.
Nakamura T; Sano M; Songyang Z; Schneider MD
Proc Natl Acad Sci U S A; 2003 May; 100(10):5834-9. PubMed ID: 12719544
[TBL] [Abstract][Full Text] [Related]
20. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
